Its activation leads to the release of pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), which reinforce obesity-related inflammation and metabolic impairment [26]. This evidence concerns the gene IL18 and obesity disorder.